Abstract
We describe a rapid, precise, and simple procedure for the quantitation of azlocillin in serum and in aqueous solutions by high-pressure, reverse-phase liquid chromatography. This method uses a single precipitation step, detection by dual-wavelength monitoring (220 and 254 nm), and quantitation by comparison with an internal standard. The 10-micron C18 muBondapak column was eluted with 45% (vol/vol) methanol-65% (vol/vol) phosphate buffer. The precision was 4.2 and 5.6% at 50 and 10 micrograms/ml, respectively. The assay was linear up to concentrations of 100 micrograms/ml, with recoveries of 90.4 to 110.5% from serum. The assay was sensitive to 0.4 micrograms of azlocillin per ml. The short turnover time (14 min) and small serum sample size (20 microliters) make the assay ideal for therapeutic drug monitoring and clinical pharmacokinetic studies.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alfthan O., Renkonen O. V., Ohlsson H. Treatment with azlocillin in complicated urinary tract infections. Arzneimittelforschung. 1979;29(12A):1979–1981. [PubMed] [Google Scholar]
- Coppens L., Klastersky J. Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin. Antimicrob Agents Chemother. 1979 Mar;15(3):396–399. doi: 10.1128/aac.15.3.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Daikos G. K., Giamarellou H., Hadjipolydorou K., Kanellakopoulou K. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic. Arzneimittelforschung. 1979;29(12A):1976–1978. [PubMed] [Google Scholar]
- Gau W., Horster F. A. Hochdruckflüssigkeitschromatographische Analyse von Azlocillin und seinem Penicilloat im Urin. Arzneimittelforschung. 1979;29(12A):1941–1943. [PubMed] [Google Scholar]
- Hildebrandt R., Gundert-Remy U. Improved procedure for the determination of the ureidopenicillins azlocillin and mezlocillin plasma by high-performance liquid chromatography. J Chromatogr. 1982 Mar 12;228:409–412. doi: 10.1016/s0378-4347(00)80464-8. [DOI] [PubMed] [Google Scholar]
- Norden C. W., Shaffer M. A. Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1982 Jan;21(1):62–65. doi: 10.1128/aac.21.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reeves D. S., Bywater M. J., Holt H. A., Broughall J. M. Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics. Arzneimittelforschung. 1979;29(12A):1920–1929. [PubMed] [Google Scholar]
- Schacht P., Tettenborn D., Hullmann R., Bruck H. Ergebnisse der klinischen Prüfung von Azlocillin. Arzneimittelforschung. 1979;29(12A):1981–1985. [PubMed] [Google Scholar]
- Simon H. J., Yin E. J. Microbioassay of antimicrobial agents. Appl Microbiol. 1970 Apr;19(4):573–579. doi: 10.1128/am.19.4.573-579.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart D., Bodey G. P. Azlocillin: in vitro studies of a new semisynthetic penicillin. Antimicrob Agents Chemother. 1977 May;11(5):865–870. doi: 10.1128/aac.11.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tselentis J., Cordossis T., Kosmidis J., Lambropoulos S., Melissinos K. Comparative activity and beta-lactamase stability of carbenicillin, ticarcillin, azlocillin, mezlocillin and cefotaxime. J Antimicrob Chemother. 1981 Oct;8(4):317–321. doi: 10.1093/jac/8.4.317. [DOI] [PubMed] [Google Scholar]
- Wise R. Azlocillin and mezlocillin, two new alpha-amino-substituted penicillins. A comparison of the in vitro activity with other penicillins. Arzneimittelforschung. 1979;29(12A):1929–1932. [PubMed] [Google Scholar]